ABGENIX

USPTO USPTO 1996 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark ABGENIX was filed as Word mark on 06/13/1996 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 06/06/2000. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: May 4, 2018

Trademark form Word mark
File reference 75118177
Register number 2355509
Application date June 13, 1996
Publication date June 16, 1998
Entry date June 6, 2000

Trademark owner

322 Lakeside Drive
94404 Foster City
US

Trademark representatives

goods and services

1 biochemicals, namely, monoclonal antibodies and fragments thereof for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals; cell lines for research and development, for general manufacturing and for use in the manufacture of pharmaceuticals
5 pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases
31 animal embryos for laboratory use
42 pharmaceutical and biological product development consultation; and pharmaceutical and biological product development for others

ID: 1375118177